CD4 and AIDS: In last decade, more than 5% newly diagnosed HIV-1 cases with baseline CD4+ T-cell counts <50 cells/μl died in the first year in China.7 Therefore, even in the era of ART, more effective immune interventions are required for advanced AIDS patients, especially for severely immunosuppressed ones.